ArticlePharmacological reports : PR2025

Post-marketing surveillance study on the effectiveness and safety of molnupiravir in high-risk COVID-19 outpatients: a prospective case series study.

Renato Ferreira-da-Silva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.